Journals / Psikiyatri Hemşireliği Dergisi / 2014 / Cilt: 5 - Sayı: 3

The determination of treatment adherence and affecting factors among a group of patients with schizophrenia

Bir grup şizofreni hastasında tedaviye uyum ve etkileyen etmenlerin belirlenmesi

Pages
143–148
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Therefore it is important that determination of the affecting factors of treatment adherence by mental health and psychiatric nurses and working with non-governmental organizations to improve treatment adherence.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: The aim of this study is to determine treatment adherence and related factors in patient with schizophrenia.
📊
Key Findings & Data:Methods: The sample of the study was composed of 35 patients with schizophrenia, between the ages of 18-65 that were outpatient and accepted to take part in the study from March-April 2013 in 4 Schizophrenia Association in Istanbul.
💡
Conclusion & Impact:Therefore it is important that determination of the affecting factors of treatment adherence by mental health and psychiatric nurses and working with non-governmental organizations to improve treatment adherence.
🔬Design:Research Article
📍Scope:2013 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: The aim of this study is to determine treatment adherence and related factors in patient with schizophrenia. Methods: The sample of the study was composed of 35 patients with schizophrenia, between the ages of 18-65 that were outpatient and accepted to take part in the study from March-April 2013 in 4 Schizophrenia Association in Istanbul. Study data was obtained with the Medication Adherence Rating Scale (MARS), Internalized Stigma of Mental Illness Scale (ISMIS), Beck Cognitive Insight Scale (BCIS) and Multidimensional Scale of Perceived Social Support (MSPSS). Results: The mean age of the sample was 40.83±7.25. 85.7% were male and 40% were high school graduates. The mean score of MARS was found to be 6.8±1.20. There were no significant differences between genders or education; however there was a significant difference between economical status and MARS. There is no correlation between age, duration of disorder, the total number of hospitalizations and MARS, and also there is no correlation between MARS and ISMI, BCIS, MSPSS. There was a significant correlation between ISMI and BCIS. Conclusion: Treatment adherence was found to be poor in patients with schizophrenia who participated in this study. Therefore it is important that determination of the affecting factors of treatment adherence by mental health and psychiatric nurses and working with non-governmental organizations to improve treatment adherence.

Özet

Amaç: Bu çalışma, şizofreni derneklerine gelen, ayaktan takip edilen şizofreni hastalarının tedavi uyumunu ve etkileyen faktörleri belirlemek amacıyla gerçekleştirildi. Gereç ve Yöntem: Araştırmaya, Mart-Nisan 2013 tarihleri arasında, İstanbulda bulunan dört Şizofreni Derneğine üye, 18-65 yaşları arasında, DSM-IVe göre kronik şizofreni tanısı almış ve ayaktan takip edilen 35 hasta katıldı. Çalışmanın verileri anket formu, Tıbbi Tedaviye Uyum Oranı Ölçeği (TTUOÖ), Ruhsal Hastalıkların İçselleştirilmiş Damgalama Ölçeği (RHİDÖ), Beck Bilişsel İçgörü Ölçeği (BBİÖ) ve Çok Boyutlu Algılanan Sosyal Destek Ölçeği (ÇBASDÖ) ile toplandı. Bulgular: Çalışmaya katılan hastaların yaş ortalaması 40.83±7.25, olup %85.7si erkek ve %40ı lise mezunudur. Katılımcıların TTUOÖ puan ortalamaları 6.8±1.20dir. Cinsiyet, eğitim düzeyi, sosyal güvence sahibi olma ile TTUOÖ ortalama puanı gruplar arasında anlamlı fark bulunmazken, ekonomik durum ve TTUOÖ puan ortalaması arasında anlamlı bir fark belirlendi. Hastaların toplam hastaneye yatış süresi ve hastalık süresi ile TTUOÖ puan ortalaması arasında ilişki saptanmadı. TTUOÖ ile RHİDÖ, BBİÖ ve ÇBASDÖ korelasyon bulunmazken, RHİDÖ ve BBİÖ arasında anlamlı pozitif korelasyon saptandı. Sonuç: Çalışmaya katılan şizofreni hastalarının tedaviye uyumu düşük bulundu. Bu nedenle, ruh sağlığı ve psikiyatri hemşirelerinin, şizofreni hastalarında tedaviye uyumu etkileyen faktörleri belirlemeleri ve toplum ruh sağlığı alanında yapılandırılmış programları uygulamaları önerilebilir.

🔖

Cite This Article

DİKEÇ, G., KUTLU, F. Y. (2014). The determination of treatment adherence and affecting factors among a group of patients with schizophrenia. Psikiyatri Hemşireliği Dergisi, Cilt: 5 - Sayı: 3, 143–148. https://ajindex.com/articles/340441

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Olfson M, Mechanic D, Hansell S, Boyer CA, et al. Predicting medication noncompliance after hospital discharge among patients with schizoph- renia. Psychiatr Serv 2000;51:216-22
  2. Day JC, Bentall RP, Roberts C, Randall F, et al. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals. Arch Gen Psychiatry 2005;62:717-24
  3. Tsang HW, Fung KM, Corrigan PW. Psychosocial and socio-demographic correlates of medication compliance among people with schizophrenia. J Behav Ther Exp Psychiatry 2009;40:3-14
  4. Beck EM, Cavelti M, Kvrgic S, Kleim B, et al. Are we addressing the ‘right stuff’ to enhance adherence in schizophrenia? Understanding the role of insight and attitudes towards medication. Schizophr Res 2011;132:42-9
  5. Bressington D, Mui J, Gray R. Factors associated with antipsychotic medication adherence in community-based patients with schizophrenia in Hong Kong: a cross sectional study. Int J Ment Health Nurs 2013;22:35-46
  6. Uçok A, Polat A, Cakir S, Genç A. One year outcome in first episode schizophrenia. Predictors of relapse. Eur Arch Psychiatry Clin Neurosci 2006;256:37-43
  7. Byerly MJ, Nakonezny PA, Lescouflair E. Antipsychotic medication adherence in schizophrenia. Psychiatr Clin North Am 2007;30:437-52
  8. Yılmaz S, Buzlu S. Antipsikotik kullanan hastalarda ilaç yan etkileri ve ilaç uyumu. İstanbul Üniversitesi Florence Nightingale Hemşirelik Dergisi 2012;20(2 Suppl.):93-103
  9. Byrne MK, Deane FP. Enhancing patient adherence: outcomes of medication alliance training on therapeutic alliance, insight, adherence, and psychopathology with mental health patients. Int J Ment Health Nurs 2011;20:284-95
  10. Gray R. Adherence therapy; working together to improve health. A treatment manual for healthcare workers. University of East Anglia, United Kingdom. Retrieved December 7, 2012, from http://www.academia. edu/2436503/Adherence_therapy_manual
  11. Kousalya K, Vasantha J, Ponnudura R. Study on non-adherence and the effect of counselling in the pharmacological management of psychiatric patients. International Journal of Pharma and Bio Sciences 2012;3(1 Suppl.):102-9
  12. Mohamed S, Rosenheck R, McEvoy J, Swartz M, et al. Cross-sectional and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophrenia. Schizophr Bull 2009;35:336-46
  13. Çakır F, İlhem C, Yener F. Kronik psikotik hastalarda taburculuk sonrası takip ve tedaviye